Do you know what your cancer drug is up to? Answering that question is not as simple as for medicines taken by well-defined patient groups, or principally for one disease. Yet among drug classes oncology treatments hold a unique position: A frightening disease of immense scientific interest, hundreds of pipeline drugs and nearly as many protocols for single and combination treatments, a complex distribution and reimbursement, and—as information service companies tell us—unprecedented opportunities for those with the right data.
Kalorama Information estimates the worldwide cancer drug market at $54 billion.Oncology’s share of global pharmaceutical demand, while only about 5% in dollar terms,is growing at more than 10% per year
Read the full story (pdf)